Functional cure, defined as durable hepatitis B surface antigen (HBsAg) and hepatitis B virus (HBV) DNA titers below the lower limit of detection (LLOD), is associated with better clinical outcomes of chronic HBV infection and is regarded as the preferred treatment endpoint of novel therapeutic agents against HBV.
Go to Source
https://medicalxpress.com/rss-feed/